title: Human cytochrome P450scc (CYP11A1) catalyzes epoxide formation with ergosterol.
abstract: Cytochrome P450scc (P450scc) catalyzes the cleavage of the side chain of both cholesterol and the vitamin D(3) precursor, 7-dehydrocholesterol. The aim of this study was to test the ability of human P450scc to metabolize ergosterol, the vitamin D(2) precursor, and define the structure of the major products. P450scc incorporated into the bilayer of phospholipid vesicles converted ergosterol to two major and four minor products with a k(cat) of 53 mol · min(-1) · mol P450scc(-1) and a K(m) of 0.18 mol ergosterol/mol phospholipid, similar to the values observed for cholesterol metabolism. The reaction of ergosterol with P450scc was scaled up to make enough of the two major products for structural analysis. From mass spectrometry, NMR, and comparison of the NMR data to that for similar molecules, we determined the structures of the two major products as 20-hydroxy-22,23-epoxy-22,23-dihydroergosterol and 22-keto-23-hydroxy-22,23-dihydroergosterol. Molecular modeling and nuclear Overhauser effect (or enhancement) spectroscopy spectra analysis helped to establish the configurations at C20, C22, and C23 and determine the final structures of major products as 22R,23S-epoxyergosta-5,7-diene-3β,20α-diol and 3β,23S-dihydroxyergosta-5,7-dien-22-one. It is likely that the formation of the second product is through a 22,23-epoxy (oxirane) intermediate followed by C22 hydroxylation with the formation of strained 22-hydroxy-22,23-epoxide (oxiranol), which is immediately transformed to the more stable α-hydroxyketone. Molecular modeling of ergosterol into the P450scc crystal structure positioned the ergosterol side chain consistent with formation of the above products. Thus, we have shown that P450scc efficiently catalyzes epoxide formation with ergosterol giving rise to novel epoxy, hydroxy, and keto derivatives, without causing cleavage of the side chain.
authors: School of Biomedical, Biomolecular and Chemical Sciences, M310, University of Western Australia, Crawley, Western Australia 6009.   rtuckey@cyllene.uwa.edu.au.
authors: Robert C
authors: RC
authors: Tuckey
authors: Minh N
authors: MN
authors: Nguyen
authors: Jianjun
authors: J
authors: Chen
authors: Andrzej T
authors: AT
authors: Slominski
authors: Donna M
authors: DM
authors: Baldisseri
authors: Elaine W
authors: EW
authors: Tieu
authors: Jordan K
authors: JK
authors: Zjawiony
authors: Wei
authors: W
authors: Li
mesh_terms: D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000378:metabolism*; D003684:Dehydrocholesterols / Q000378:metabolism; D004852:Epoxy Compounds / Q000378:metabolism*; D004872:Ergocalciferols / Q000378:metabolism; D004875:Ergosterol / Q000031:analogs & derivatives / Q000737:chemistry* / Q000378:metabolism*; D005027:Ethylene Oxide / Q000378:metabolism; D006801:Humans; D006900:Hydroxylation; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D013058:Mass Spectrometry / Q000379:methods; D010743:Phospholipids / Q000378:metabolism
chemical_list: D003684:Dehydrocholesterols; D004852:Epoxy Compounds; D004872:Ergocalciferols; D010743:Phospholipids; C012287:22,23-dihydroergosterol; C016705:7-dehydrocholesterol; D002786:Cholesterol Side-Chain Cleavage Enzyme; D005027:Ethylene Oxide; D004875:Ergosterol